Fidaxomycin (Dificlir) for the indication Clostridium difficile-related disease

In the treatment of patients with CDAD who are severely ill or who have been admitted to hospital, the therapeutic value of fidaxomycin is comparable with that of metronidazole and vancomycin.

This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.